Investing

Intangible Purchases

Moderna Intangible Purchases decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $10.00M to $0.00.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026

How to read this metric

Higher spending indicates a focus on R&D and future-proofing the product portfolio.

Detailed definition

This metric tracks cash outflows for the acquisition or development of intangible assets, including software, patents, a...

Peer comparison

Highly relevant for software and tech companies; often compared against R&D expense ratios.

Metric ID: purchases_of_intangibles

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q1 '26
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$10.00M$0.00
QoQ Change-100.0%
YoY Change-100.0%
Range$0.00$10.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%

Intangible Purchases at Other Companies

Frequently Asked Questions

What is Moderna's intangible purchases?
Moderna (MRNA) reported intangible purchases of $0.00 in Q1 2026.
How has Moderna's intangible purchases changed year-over-year?
Moderna's intangible purchases decreased by 100.0% year-over-year, from $10.00M to $0.00.
What does intangible purchases mean?
Cash spent on acquiring or developing software and other intangible assets.